Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 24

Strontium titanate was once used as a diamond substitute in jewelry before less fragile alternatives emerged in the 1970s. Now, researchers have explored some of its more unusual properties, which might someday be useful in quantum materials and microelectronics applications.

Writing in the journal Nature Communications, the team explains how they built an extremely thin, flexible strontium titanate membrane and stretched it, in the process turning on what’s known as a ferroelectric state. In that state, the material generates its own , somewhat similar to how a generates its own magnetic field.

“We applied strain to tune the membrane to a ferroelectric or non-ferroelectric state reversibly and repeatedly,” said Wei-Sheng Lee, a lead scientist at the Department of Energy’s SLAC National Accelerator Laboratory and a principal investigator at the Stanford Institute for Materials and Energy Sciences (SIMES), a joint SLAC-Stanford institute. “This allowed quantitative characterizations of this transition in strontium titanate with unprecedented details.”

Read more | >

With global population growth accelerating urban expansion, construction activity has reached unprecedented levels—placing immense pressure on both natural resources as well as the environment. A cornerstone of modern-day infrastructure, Ordinary Portland Cement remains the most effective and commonly used soil solidifier despite contributing substantially to global carbon emissions.

At the same time, continues to accumulate in landfills. Addressing both the environmental burden of cement use and the inefficiencies of industrial waste disposal has become an urgent priority.

To tackle these interconnected challenges, scientists from Japan, led by Professor Shinya Inazumi, from the College of Engineering, Shibaura Institute of Technology (SIT), Japan, present a sustainable alternative: a high-performance geopolymer-based soil solidifier developed from Siding Cut Powder (SCP), a construction waste byproduct, and earth silica (ES), sourced from recycled glass.

Read more | >

In this episode of The Moss Report, Ben Moss sits down with Dr. Ralph Moss to explore the real-world pros and cons of using artificial intelligence in cancer research and care.

From AI-generated health advice to PubMed citations that don’t exist, this honest conversation covers what AI tools are getting right—and where they can dangerously mislead.

Dr. Moss shares the results of his own AI test across five major platforms, exposing their strengths and surprising failures.

Whether you’re a cancer patient, caregiver, or simply curious about how AI is shaping the future of medicine, this episode is essential listening.

Links and Resources:

🌿 The Moss Method – Fight Cancer Naturally – (Paperback, Hardcover, Kindle) https://amzn.to/4dGvVjp.

Continue reading “AI & Cancer: What Worked, What Failed, and Why It Matters” | >

Scientists in Europe have tested an anti-aging drug cocktail in mice and found that it extended the animals’ lifespans by around 30 percent. The mice stayed healthier for longer too, with less chronic inflammation and delayed cancer onset.

The two drugs are rapamycin and trametinib, which are both used to treat different types of cancer. Rapamycin is also often used to prevent organ rejection, and has shown promise in extending lifespans in animal tests. Trametinib, meanwhile, has been shown to extend the lifespan of fruit flies, but whether that worked in larger animals remained to be seen.

So for a new study, a research team led by scientists from the Max Planck Institute in Germany investigated how both drugs, on their own and together, could extend lifespan in mice.

Read more | >

A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients.

The breakthrough, a between Distinguished Professor Gordon Wallace and Professor Caiyun Wang from the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong (UOW) and researchers from Jilin University in China, is outlined in a new paper published in Science Advances.

Biobatteries have the same basic parts as regular batteries—two electrodes (anode and cathode), a separator and an electrolyte—but use biological processes to create electricity. The paper examines how biobatteries can be used to target tumors and spark a localized immunotherapy response in the body.

Read more | >